Search

Author/Creator Leong, Rupert W.L.

1. Corticosteroid Sparing Effects of Ustekinumab Therapy in UC Patients: Results From the UNIFI Program: 715. (October 2019)

Authors:
Danese, Silvio; Sands, Bruce E.; Peyrin‐Biroulet, Laurent; Marano, Colleen; O'Brien, Christopher; Zhang, Hongyan; Oortwijn, Alessandra; Rowbotham, David; Leong, Rupert W.L.; Arasaradnam, Ramesh P.; Van Assche, Gert; Sandborn, William J.; Panaccione, Remo
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease. Issue 7 (July 2018)

Authors:
Chan, Webber; Lynch, Nicole; Bampton, Peter; Chang, Jeff; Chung, Alvin; Florin, Timothy; Hetzel, David J.; Jakobovits, Simon; Moore, Gregory; Pavli, Paul; Radford-Smith, Graham; Thin, Lena; Baraty, Brandon; Haifer, Craig; Yau, Yunki; Leong, Rupert W.L.
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 30:Issue 7(2018:Jul.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis. (1st October 2014)

Authors:
Leong, Rupert W.L.; Huang, Tony; Ko, Yanna; Jeon, Ari; Chang, Jeff; Kohler, Friedbert; Kariyawasam, Viraj
Journal:
Journal of Crohn's and colitis
Issue:
Volume 8:Number 10(2014:Oct.)
Page Start:
1237
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗